Dr. Tharp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1104 Kyle Wood Ln
Brandon, FL 33511Phone+1 813-948-7550- Is this information wrong?
Summary
- Dr. Michael Tharp is the Medical Director of True Blue Clinical Research in Tampa and Brandon, FL. He received his medical degree from Ohio State University College of Medicine, is boarded in Dermatology and Internal Medicine and has been in practice 43 years which includes clinical research. He is experienced in complex general dermatologic problems, atopic dermatitis, psoriasis, urticaria, mastocystosis and cutaneous malignancies. He has more than 170 publications and over 500 citings.
Education & Training
Duke University HospitalResidency, Dermatology, 1977 - 1980
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1974 - 1977
Ohio State University College of MedicineClass of 1974
Certifications & Licensure
FL State Medical License 2017 - 2025
IL State Medical License 1995 - 2020
TX State Medical License 1981 - 2003
NC State Medical License 1977 - 2002
PA State Medical License 1987 - 1996- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Clinical Trials
- Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Start of enrollment: 1996 Nov 01
- Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis Start of enrollment: 2008 Jan 01
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concep...Myers, D., Annis, K., Graham, D., Zang, C., Vlahos, B., Sanders, P., Silverberg, J., Kirsner, R., Margolis, D., Tharp, M.> ;Journal of the American Academy of Dermatology. 2024 Feb 7
- 3 citationsPrinciples of Moisturizer Product DesignChristine Marie Nixon Lee, John Steven Bajor, Teanoosh Moaddel, Vivek Subramanian, Jianming Lee, Diana Marrero, Sheila Alves Rocha, Michael D. Tharp> ;Journal of Drugs in Dermatology. 2019 Jan 1
- 62 citationsBenefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” EvidenceMichael D. Tharp, Jonathan A. Bernstein, Abhishek Kavati, Benjamin Ortiz, Karen MacDonald, Kris Denhaerynck, Ivo Abraham, Christopher S. Lee> ;JAMA Dermatology. 2019 Jan 1
- Join now to see all
Journal Articles
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients with Chronic Idiopathic (Spontaneous) UrticariaJonathan A Bernstein, Michael D Tharp, Ivo Abraham, JAMA
Grant Support
- Rodent And Human Skin MAST Cell CytotoxicityNational Cancer Institute1988–1990
- MAST Cell Function In Human SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986
- MAST Cell Function In Human SkinNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Member
- Fellow/Past Member of the BOD
- Society for Investigative DermatologyMember/Past Vice President
- Dermatology FoundationPast President, Board of Directors
- Chicago Dermatological SocietyMember
- Noah Worcester SocMember
- Association of Professors of DermatologyMember/Past President
- American Dermatological AssocMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
